Global and China Fragment-based Drug Discovery Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 22-Sep-2021
No. of pages: 108
Inquire Before Buying

Global Fragment-based Drug Discovery Scope and Market Size

Fragment-based Drug Discovery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fragment-based Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Fragment Screening

- Fragment Optimization

Segment by Application

- Academic and Research Institutions

- Biopharmaceutical Companies

- Contract Research Organizations (CROs)

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Astex Pharmaceuticals

- Alveus Pharmaceuticals

- Beactica

- Charles River Laboratories

- Crown Bioscience

- Emerald BioStructures

- Evotec

- Kinetic Discovery

- Proteros Fragments

- Sprint Bioscience

- Structure Based Design

- Sygnature Discovery

Global and China Fragment-based Drug Discovery Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2016-2027)
2.2 Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fragment-based Drug Discovery Historic Market Share by Regions (2016-2021)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027)
2.3 Fragment-based Drug Discovery Industry Dynamic
2.3.1 Fragment-based Drug Discovery Market Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Revenue
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2016-2021)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2016-2021)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2020
3.5 Fragment-based Drug Discovery Key Players Head office and Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2016-2021)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2016-2021)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2016-2027)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2016-2021)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2022-2027)
6.2.3 North America Fragment-based Drug Discovery Market Size by Type (2016-2027)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2016-2021)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2022-2027)
6.3.3 North America Fragment-based Drug Discovery Market Size by Application (2016-2027)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country (2016-2021)
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2016-2027)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2016-2021)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2022-2027)
7.2.3 Europe Fragment-based Drug Discovery Market Size by Type (2016-2027)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2016-2021)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2022-2027)
7.3.3 Europe Fragment-based Drug Discovery Market Size by Application (2016-2027)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country (2016-2021)
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2016-2027)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type
8.2.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2027)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application
8.3.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2027)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.4.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2016-2027)
9.2 Latin America Fragment-based Drug Discovery Market Size by Type
9.2.1 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021)
9.2.2 Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027)
9.2.3 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2027)
9.3 Latin America Fragment-based Drug Discovery Market Size by Application
9.3.1 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021)
9.3.2 Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027)
9.3.3 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2027)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country
9.4.1 Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021)
9.4.2 Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2016-2027)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2027)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2027)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.1.5 Astex Pharmaceuticals Recent Development
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.2.5 Alveus Pharmaceuticals Recent Development
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.3.5 Beactica Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.4.5 Charles River Laboratories Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.5.5 Crown Bioscience Recent Development
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.6.5 Emerald BioStructures Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.7.5 Evotec Recent Development
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.8.5 Kinetic Discovery Recent Development
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.9.5 Proteros Fragments Recent Development
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.10.5 Sprint Bioscience Recent Development
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.11.5 Structure Based Design Recent Development
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.12.5 Sygnature Discovery Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Fragment-based Drug Discovery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fragment-based Drug Discovery Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Regions (2016-2021)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Market Share by Players (2016-2021)
Table 16. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020)
Table 17. Ranking of Global Top Fragment-based Drug Discovery Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 21. Date of Enter into Fragment-based Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Fragment-based Drug Discovery Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Market Share by Application (2016-2021)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 61. Astex Pharmaceuticals Company Details
Table 62. Astex Pharmaceuticals Business Overview
Table 63. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 64. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 65. Astex Pharmaceuticals Recent Development
Table 66. Alveus Pharmaceuticals Company Details
Table 67. Alveus Pharmaceuticals Business Overview
Table 68. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 69. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 70. Alveus Pharmaceuticals Recent Development
Table 71. Beactica Company Details
Table 72. Beactica Business Overview
Table 73. Beactica Fragment-based Drug Discovery Product
Table 74. Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 75. Beactica Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Fragment-based Drug Discovery Product
Table 79. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. Crown Bioscience Company Details
Table 82. Crown Bioscience Business Overview
Table 83. Crown Bioscience Fragment-based Drug Discovery Product
Table 84. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 85. Crown Bioscience Recent Development
Table 86. Emerald BioStructures Company Details
Table 87. Emerald BioStructures Business Overview
Table 88. Emerald BioStructures Fragment-based Drug Discovery Product
Table 89. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 90. Emerald BioStructures Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec Fragment-based Drug Discovery Product
Table 94. Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 95. Evotec Recent Development
Table 96. Kinetic Discovery Company Details
Table 97. Kinetic Discovery Business Overview
Table 98. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 99. Kinetic Discovery Recent Development
Table 100. Proteros Fragments Company Details
Table 101. Proteros Fragments Business Overview
Table 102. Proteros Fragments Fragment-based Drug Discovery Product
Table 103. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 104. Proteros Fragments Recent Development
Table 105. Sprint Bioscience Company Details
Table 106. Sprint Bioscience Business Overview
Table 107. Sprint Bioscience Fragment-based Drug Discovery Product
Table 108. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 109. Sprint Bioscience Recent Development
Table 110. Structure Based Design Company Details
Table 111. Structure Based Design Business Overview
Table 112. Structure Based Design Fragment-based Drug Discovery Product
Table 113. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 114. Structure Based Design Recent Development
Table 115. Sygnature Discovery Company Details
Table 116. Sygnature Discovery Business Overview
Table 117. Sygnature Discovery Fragment-based Drug Discovery Product
Table 118. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 119. Sygnature Discovery Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Share by Type: 2020 VS 2027
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2027
Figure 5. Academic and Research Institutions Case Studies
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Contract Research Organizations (CROs) Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Fragment-based Drug Discovery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Fragment-based Drug Discovery Market Share by Regions: 2020 VS 2027
Figure 12. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Figure 13. Global Fragment-based Drug Discovery Market Share by Players in 2020
Figure 14. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2020
Figure 16. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Figure 17. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027)
Figure 18. North America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 20. North America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 21. North America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 22. United States Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 26. Europe Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 27. Europe Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 28. Germany Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Fragment-based Drug Discovery Market Share by Region (2016-2027)
Figure 38. China Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 46. Latin America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 47. Latin America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 48. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 54. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 58. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 59. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 60. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 61. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 62. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 63. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 64. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 65. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 66. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 67. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 68. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs